ArticleLeukemia2024

Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.

Wenyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.